The Minimal Residual Disease in Non-Hodgkin's Lymphomas: From the Laboratory to the Clinical Practice

Minimal residual disease (MRD) in non-Hodgkin's lymphomas (NHLs) still represents matter of interest and debate: indeed, the new available treatments offer higher rates of complete responses and MRD negativity than in the past, with a positive impact on the long-term survival. Furthermore, the...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Oncol
Главные авторы: Galimberti, Sara, Genuardi, Elisa, Mazziotta, Francesco, Iovino, Lorenzo, Morabito, Fortunato, Grassi, Susanna, Ciabatti, Elena, Guerrini, Francesca, Petrini, Mario
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2019
Предметы:
Oncology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6606710/
https://ncbi.nlm.nih.gov/pubmed/31293969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00528
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы